Ambu

AGM Information • Dec 16, 2010

Company announcement no. 06 2010/11 16 December 2010

Annual General Meeting in Ambu A/S on 16 December 2010

Ambu A/S today held its annual general meeting.

The shareholders considered the management's review, and the Annual Report for 2009/10 was adopted.

The distribution of the profit for the year was adopted, and dividend of DKK 2.50 per share will consequently be distributed, corresponding to 35% of the net profit.

N.E. Nielsen and Anders Williamsson were reelected for the Board of Directors. Jens Bager, President & CEO of ALK-Abelló A/S og Mikael Worning, Executive Vice President of Oticon A/S were elected as new members of the Board replacing previous members Jørgen Hartzberg and Torben Ladegaard, Group Managing Director of FOSS A/S.

The company auditors PricewaterhouseCoopers Statsautoriseret Revisionsaktieselskab were reappointed.

Furthermore, the Board of Directors was authorised to acquire, in the period until next year's annual general meeting, treasury shares representing up to 10% of the share capital and at the bid price quoted by the Nasdaq OMX Copenhagen plus or minus up to 10%.

Amendments to the Articles of Association as a result of the new Danish Companies Act (Selskabsloven) and other modernisations, including a change of the term for which the Board of Directors is elected to one year was adopted. A proposal for the introduction of an incentive programme in the form of warrants for the group's management team was adopted, while also a proposal for the launch of an employee share programme was adopted.

A proposal from a shareholder was discussed but the proposer did not want to put the proposal to a vote.

At the following meeting of the Board of Directors, Chairman of the Board N. E. Nielsen and Deputy Chairman of the Board Bjørn Ragle were reelected. At the same time a fee and nomination committee consisting of Bjørn Ragle, Jens Bager and N.E. Nielsen was formed, and an audit committee consisting of John Stær and Mikael Worning was formed.

Further information: Lars Marcher, CEO, phone +45 5136 2490, e-mail: lm@ambu.com

Ambu develops, produces and markets diagnostic and life-supporting devices to hospitals and rescue services. Ambu has three business areas: Airway Management, Patient Monitoring & Diagnostics and Emergency Care.

Ambu's high-quality products are innovative and unique. Ambu has a favourable market position in its chosen focus areas.

Ambu's products are sold worldwide. Exports account for 98% of sales, and sales are handled via Ambu's foreign subsidiaries or via distributors. Ambu has approx. 1,700 employees, of whom 300 work in Denmark and 1,400 abroad.